However, it is unclear whether CCL5 in gliomas would also trigger similar Treg inhibition toward CD8+ TILs, as we only found a negligible population (<2%) of Treg characterized as Foxp3+ CD4+ (data not shown). The gene discussed is CD4; the disease is central nervous system cancer.